| Approved? (Admin-only) |
|
|---|---|
| Opportunity Type | Pre-Release |
| Funding Opportunity Posted By | DOW |
| Component | DHA - CDMRP |
| Funding Opportunity Title | Joint Warfighter Medical Research Program |
| Link to Funding Opportunity | health.mil |
| Funding Opportunity Short Description | To augment and accelerate progress toward critical Department of War (DOW) medical capability gaps and requirements through the continuation of research and development initiatives that were previously supported by DOW core and/or DOW congressionally directed funding and that are close to achieving their objectives and yielding a benefit to military medicine. |
| Funding Opportunity Category | Health and Biomedical Technologies |
| Important Dates | |
| Funding Details | |
| Award Floor | $1,250,000.00 |
| Award Ceiling | $3,000,000.00 |
| Eligibility |
|
| Required Registrations |
|
| Funding Opportunity Full Description | The FY26 Defense Appropriations Act provides funding for the Joint Warfighter Medical Research Program (JWMRP) to augment and accelerate progress toward critical Department of War (DOW) medical capability gaps and requirements through the continuation of research and development initiatives that were previously supported by DOW core and/or DOW congressionally directed funding and that are close to achieving their objectives and yielding a benefit to military medicine. As part of the Defense Health Agency Research & Development - Medical Research and Development Command (DHA R&D-MRDC), the Congressionally Directed Medical Research Programs (CDMRP) is the program office managing this FY26 funding opportunity. The JWMRP is providing the information in this pre-announcement to allow investigators time to plan and develop ideas for submission to the anticipated FY26 funding opportunity. Investigators should not construe this pre-announcement as an obligation or promise by the government. The CDMRP will post FY26 JWMRP funding opportunity announcements on the Grants.gov website. Once released, the funding opportunity announcements will include pre-application and application deadlines. Applications submitted to the FY26 JWMRP must address one or more of the following focus areas: Non-vaccine approaches to prevent endemic diarrheal disease and broad-spectrum antivirals to prevent and/or treat emerging or endemic infectious diseases, excluding malaria |
